MOBI · Mobia Medical, Inc.
$10.95
-0.47 (-4.12%)
At close · Aug 20
Going-concern doubt
— cleared Aug 11, 2026
The latest filing states the doubt was alleviated.
“In prior reporting periods, the Company concluded that recurring operating losses, negative cash flows from operations, and future expenditures raised substantial doubt about its ability to continue as a going concern. In May 2026, the Company completed its IPO and received net proceeds of approximately $134.0 million. As a result of the additional liquidity provided by the completed IPO, management concluded that the existing cash and cash equivalents are sufficient to fund its operations and meet its obligations for at least one year from the date these condensed unaudited interim financial statements are issued. Accordingly, management concluded that the conditions and events described above do not raise substantial doubt about the Company's ability to continue as a going concern.”View the 10-Q filed Aug 11, 2026
Market Cap
$380.18M
Shares
33.29M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$10.95
Open$11.30
Day$10.89–12.10
Available close range$10.43–14.63
Avg vol 30d102K
Short int480K · 1.4% float · 6.2d
Short vol60%
Last earningsAug 11, 2026
DataMay 2026–Aug 2026
Filing10-Q · Aug 11
The closing range uses available history since May 8, 2026; less than a full year is stored.
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed Aug 11, 2026
Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Strong Sell
Momentum
Limited
Sentiment
Neutral
Fundamentals
Limited
Quant / Vol
Very High
Market backdrop
VIX 14.9 · calm
Equity put/call 0.52
Technical
price trend
50 / 200-day cross
No cross
Price vs 50-day avg
−11%
below
RSI (14)
40
neutral
MACD trend
Negative
52-week position
12%
near low
Momentum
relative strength
Not enough data for a confident read.
Sentiment
smart money
Trend (MA cross)
No cross
50/200-day averages unavailable
Institutional flow
Accumulating
+42 funds added
Insider flow
Accumulating
Net +$1.1M over 90 days · 0% sells
Short interest
Rising
1.44% of float · ▲ +13.6% MoM · 6.2 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
42 holders — 13F breadth
Squeeze score
50
elevated · 0–100
Fundamentals
Not enough data for a confident read.
Quant / Vol
risk profile
Volatility
77%
annualized · 1-yr
Max drawdown
−29%
past year
ATR
9.4%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Latest guidance
· from the 8-K filed Aug 11, 2026
Revenue
· full year 2026
Initiated
$54M – $56M
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Strong Sell
50 / 200-day cross
No cross
Neutral
Price vs 50-day avg
−11%
Bearish
RSI (14)
40
Neutral
MACD trend
Negative
Bearish
52-week position
12%
Bearish
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross)
No cross
50/200-day averages unavailable
Institutional flow
Accumulating
+42 funds added
Insider flow
Accumulating
Net +$1.1M over 90 days · 0% sells
Short interest
Rising
1.44% of float · ▲ +13.6% MoM · 6.2 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
42 holders — 13F breadth
Price context
position in its available closing range
Range low $10
Now $11 · 12%
Range high $15
vs 50-day avg -11%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Gross margin | 83.2% | the three months ended June 30, 2026 filing | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Medical Devices — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
MOBI
this stock
Mobia Medical, Inc.
|
$380.18M | — | — | — | 1.4% |
|
ABT
Abbott Laboratories
|
$198.81B | -8.9% | +5.7% | 32.0 | 1.3% |
|
SYK
Stryker Corp
|
$127.26B | -6.8% | +11.2% | 34.4 | 2.2% |
|
MDT
Medtronic plc
|
$120.49B | -3.9% | +8.4% | 25.2 | 1.4% |
|
BSX
Boston Scientific Corp
|
$71.55B | -48.2% | +12.5% | 20.0 | 1.5% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| MOBI | -6.3% | -1.0% | — | -2.1% | — |
| SPY | -2.0% | +3.3% | +11.2% | +2.1% | +11.8% |
| vs SPY | -4.3% | -4.3% | — | -4.1% | — |
Key facts
CIK
1489993
CUSIP
60705V103
13F (30d)
44 filings
44 filers
Visit website
Investor relations